Local FL media claims it’s only two “ineffective” monoclonals and there’s others available
The FDA revoked the EUA for Regeneron and Eli Lily mAb therapies as those two specifically have near zero effectiveness against omicron. They did not revoke the EUA for Sotrovimab which has diminished effects on Omc but not near zero like the other two. Given that the dominant 99.5% of cases now are the much more transmission prone omicron strain the shift should be to these others that work on that. There is another approved one as well. Both are in short supply due to the huge surge in omicron cases and the demand for those two mAb
“Evusheld, developed by Astra-Zeneca, is a combination of two antibodies tixagevimab and cilgavimab, both of which were isolated from Covid-19 patients. “
They say it’s because less effective against Omicron- but they’re playing God denying it because no one is actually TESTED for Omicron so seems reckless to me to deny the treatment-Russian roulette with life again. If it won’t hurt and could help why-oh wait — like Ivermectin or HCQ /s